Nosocomial fungal infections: epidemiology, diagnosis, and treatment.
暂无分享,去创建一个
[1] E. Freireich,et al. Influence of high-efficiency particulate air filtration on mortality and fungal infection: a rebuttal. , 2006, The Journal of infectious diseases.
[2] K. Garey,et al. Association of Fluconazole Area under the Concentration-Time Curve/MIC and Dose/MIC Ratios with Mortality in Nonneutropenic Patients with Candidemia , 2006, Antimicrobial Agents and Chemotherapy.
[3] B. Spellberg,et al. Deferiprone iron chelation as a novel therapy for experimental mucormycosis. , 2006, The Journal of antimicrobial chemotherapy.
[4] B. Spellberg,et al. Deferasirox, an Iron-Chelating Agent, as Salvage Therapy for Rhinocerebral Mucormycosis , 2006, Antimicrobial Agents and Chemotherapy.
[5] L. Wheat. Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host , 2006, Transplant infectious disease : an official journal of the Transplantation Society.
[6] C. Claussen,et al. Long-term CT follow-up in 40 non-HIV immunocompromised patients with invasive pulmonary aspergillosis: kinetics of CT morphology and correlation with clinical findings and outcome. , 2006, AJR. American journal of roentgenology.
[7] K. Garey,et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] W. Bilker,et al. Reemergence of gram-negative health care-associated bloodstream infections. , 2006, Archives of internal medicine.
[9] L. Bevanger,et al. Candidemia in Norway (1991 to 2003): Results from a Nationwide Study , 2006, Journal of Clinical Microbiology.
[10] K. Wood,et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.
[11] T. Eckmanns,et al. The influence of high-efficiency particulate air filtration on mortality and fungal infection among highly immunosuppressed patients: a systematic review. , 2006, The Journal of infectious diseases.
[12] J. Fine,et al. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] J. Graybill,et al. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] A. Standaert,et al. Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links , 2006, BMC infectious diseases.
[15] B. Spellberg,et al. The Anti-Candida Vaccine Based on the Recombinant N-Terminal Domain of Als1p Is Broadly Active against Disseminated Candidiasis , 2006, Infection and Immunity.
[16] Kieren A. Marr,et al. Clinical Significance of Azole Antifungal Drug Cross-Resistance in Candida glabrata , 2006, Journal of Clinical Microbiology.
[17] D. Kontoyiannis,et al. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] G. Klintmalm,et al. Combination of Voriconazole and Caspofungin as Primary Therapy for Invasive Aspergillosis in Solid Organ Transplant Recipients: A Prospective, Multicenter, Observational Study , 2006, Transplantation.
[19] M. Bassetti,et al. Epidemiological trends in nosocomial candidemia in intensive care , 2006, BMC infectious diseases.
[20] R. Porcher,et al. Occurrence and Kinetics of False-Positive Aspergillus Galactomannan Test Results following Treatment with β-Lactam Antibiotics in Patients with Hematological Disorders , 2006, Journal of Clinical Microbiology.
[21] M. Choti,et al. Triazole Cross-Resistance among Candida spp.: Case Report, Occurrence among Bloodstream Isolates, and Implications for Antifungal Therapy , 2006, Journal of Clinical Microbiology.
[22] S. Filler,et al. Current treatment strategies for disseminated candidiasis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] D. Kontoyiannis,et al. Posaconazole: a broad-spectrum triazole antifungal. , 2005, The Lancet. Infectious diseases.
[24] A. Baruch,et al. Safety and Pharmacokinetics of Coadministered Voriconazole and Anidulafungin , 2005, Journal of clinical pharmacology.
[25] Axel A Brakhage,et al. Systemic fungal infections caused by Aspergillus species: epidemiology, infection process and virulence determinants. , 2005, Current drug targets.
[26] U. Nawrot,et al. Susceptibility to antifungal agents of Candida species isolated from paediatric and adult patients with haematological diseases , 2005, Mycoses.
[27] Michael Y. Lin,et al. Prior Antimicrobial Therapy and Risk for Hospital-Acquired Candida glabrata and Candida krusei Fungemia: a Case-Case-Control Study , 2005, Antimicrobial Agents and Chemotherapy.
[28] J. Morgan. Global trends in candidemia: Review of reports from 1995–2005 , 2005, Current infectious disease reports.
[29] J. Berlin,et al. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] C. Viscoli,et al. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial , 2005, The Lancet.
[31] L. Leibovici,et al. Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. , 2005, The Journal of hospital infection.
[32] D. Denning,et al. Laboratory diagnosis of invasive aspergillosis. , 2005, The Lancet. Infectious diseases.
[33] C. Kauffman,et al. Candida glabrata fungemia: experience in a tertiary care center. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] P. Pitisuttithum,et al. Activity of posaconazole in the treatment of central nervous system fungal infections. , 2005, The Journal of antimicrobial chemotherapy.
[35] J. Perfect,et al. Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole. , 2005, Transplantation.
[36] M. Motyl,et al. Caspofungin Susceptibility Testing of Isolates from Patients with Esophageal Candidiasis or Invasive Candidiasis: Relationship of MIC to Treatment Outcome , 2005, Antimicrobial Agents and Chemotherapy.
[37] K. J. Lee,et al. CT halo sign: the spectrum of pulmonary diseases. , 2005, The British journal of radiology.
[38] C. Lengerke,et al. Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome? , 2005, European journal of radiology.
[39] D. Kontoyiannis,et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[40] Victoria J. Fraser,et al. Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality , 2005, Antimicrobial Agents and Chemotherapy.
[41] W. Steinbach. Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies. , 2005, Current drug targets. Infectious disorders.
[42] C. Lengerke,et al. Invasive pulmonary aspergillosis: frequency and meaning of the "hypodense sign" on unenhanced CT. , 2005, The British journal of radiology.
[43] F. Gavini,et al. Bifidobacterial Lipoglycan as a New Cause for False-Positive Platelia Aspergillus Enzyme-Linked Immunosorbent Assay Reactivity , 2005, Journal of Clinical Microbiology.
[44] Brad Spellberg,et al. Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management , 2005, Clinical Microbiology Reviews.
[45] D. Kontoyiannis,et al. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[46] M. Cappellini. Iron-chelating therapy with the new oral agent ICL670 (Exjade). , 2005, Best practice & research. Clinical haematology.
[47] S. Fridkin,et al. Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003 , 2005, Journal of Clinical Microbiology.
[48] R. Labrom,et al. Disseminated Scedosporium prolificans infection and survival of a child with acute lymphoblastic leukemia. , 2005, The Pediatric infectious disease journal.
[49] N. Chao,et al. Pharmacokinetic and Maximum Tolerated Dose Study of Micafungin in Combination with Fluconazole versus Fluconazole Alone for Prophylaxis of Fungal Infections in Adult Patients Undergoing a Bone Marrow or Peripheral Stem Cell Transplant , 2005, Antimicrobial Agents and Chemotherapy.
[50] P. Chevallier,et al. Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] B. Arthington-Skaggs,et al. Rapid Acquisition of Stable Azole Resistance by Candida glabrata Isolates Obtained before the Clinical Introduction of Fluconazole , 2005, Antimicrobial Agents and Chemotherapy.
[52] B. Spellberg,et al. Caspofungin Inhibits Rhizopus oryzae 1,3-β-d-Glucan Synthase, Lowers Burden in Brain Measured by Quantitative PCR, and Improves Survival at a Low but Not a High Dose during Murine Disseminated Zygomycosis , 2005, Antimicrobial Agents and Chemotherapy.
[53] M. Cuenca‐Estrella,et al. In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003. , 2005, The Journal of antimicrobial chemotherapy.
[54] B. Spellberg,et al. Combination Therapy with Amphotericin B Lipid Complex and Caspofungin Acetate of Disseminated Zygomycosis in Diabetic Ketoacidotic Mice , 2005, Antimicrobial Agents and Chemotherapy.
[55] J. Sierra,et al. Efficacy and toxicity of intermediate-dose amphotericin B lipid complex as a primary or salvage treatment of fungal infections in patients with hematological malignancies , 2005, Leukemia & lymphoma.
[56] Nina Singh,et al. Aspergillus Infections in Transplant Recipients , 2005, Clinical Microbiology Reviews.
[57] S. Pitlik,et al. Unexpected candidemia complicating ureteroscopy and urinary stenting , 1998, European Journal of Clinical Microbiology and Infectious Diseases.
[58] J. Singer,et al. Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients , 1997, European Journal of Clinical Microbiology and Infectious Diseases.
[59] E. Bouza,et al. Cutaneous mucormycosis in a heart transplant patient associated with a peripheral catheter , 1995, European Journal of Clinical Microbiology and Infectious Diseases.
[60] Nina Singh,et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[61] D. Denning,et al. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[62] U. Theuretzbacher. Pharmacokinetics/pharmacodynamics of echinocandins , 2004, European Journal of Clinical Microbiology and Infectious Diseases.
[63] K. P. Sheka,et al. Management of bronchovascular mucormycosis in a diabetic: a surgical success. , 2004, The Annals of thoracic surgery.
[64] Ray Y. Hachem,et al. Aspergillus terreus , 2004, Cancer.
[65] M. Pfaller,et al. Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus , 2004, Journal of Clinical Microbiology.
[66] M. Boeckh,et al. Combination antifungal therapy for invasive aspergillosis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[67] I. Buysschaert,et al. Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole? , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[68] J. Englund,et al. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[69] C. Kauffman. Zygomycosis: reemergence of an old pathogen. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[70] L. Bartelt,et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[71] T. Walsh,et al. Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children. , 2004, The Pediatric infectious disease journal.
[72] R. Wenzel,et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[73] G. Morace,et al. In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei , 2004, European Journal of Clinical Microbiology and Infectious Diseases.
[74] A. Kanamaru,et al. Microbiological data for patients with febrile neutropenia. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[75] J. Perfect,et al. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[76] E. Thiel,et al. Improved Outcome of Zygomycosis in Patients with Hematological Diseases? , 2004, Leukemia & lymphoma.
[77] C. Wallis,et al. Primary cutaneous mucormycosis masquerading as pyoderma gangrenosum , 2004, The British journal of dermatology.
[78] J. Donnelly,et al. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. , 2004, The Lancet. Infectious diseases.
[79] D. Swinne,et al. In vitro activities of voriconazole (UK‐109, 496), fluconazole, itraconazole and amphotericin B against 132 non‐albicans bloodstream yeast isolates (CANARI study) , 2004, Mycoses.
[80] H. Yamaguchi,et al. A Multicenter, Open-Label Clinical Study of Micafungin (FK463) in the Treatment of Deep-seated Mycosis in Japan , 2004, Scandinavian journal of infectious diseases.
[81] E. Anaissie,et al. Fusarium infection in hematopoietic stem cell transplant recipients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[82] J. Leroy,et al. Zygomycosis caused by Cunninghamella bertholletiae in a kidney transplant recipient. , 2004, Medical mycology.
[83] Lee H. Harrison,et al. Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program , 2004, Journal of Clinical Microbiology.
[84] J. Bourhis,et al. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[85] F. Marty,et al. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. , 2004, The New England journal of medicine.
[86] H. O. D. Camp,et al. Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detection , 2004, The Lancet.
[87] J. Sobel,et al. Guidelines for treatment of candidiasis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[88] F. Derouin,et al. Successful Treatment of Pulmonary Mucormycosis in an Allogenic Bone-marrow Transplant Recipient with Combined Medical and Surgical Therapy , 2004, Scandinavian journal of infectious diseases.
[89] W. Bechstein,et al. Fungal infections in liver transplant recipients , 1985, Langenbecks Archiv für Chirurgie.
[90] T J Walsh,et al. Infections due to emerging and uncommon medically important fungal pathogens. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[91] J. Pemán,et al. Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain , 2004, European Journal of Clinical Microbiology and Infectious Diseases.
[92] E. Mellado,et al. Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients , 2004, Intensive Care Medicine.
[93] A. Sulahian,et al. False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. , 2003, The New England journal of medicine.
[94] Jien-Wei Liu,et al. Rhinocerebral mucormycosis in Taiwan. , 2003, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[95] N. Katsilambros,et al. Mucormycosis: Ten-Year Experience at a Tertiary-Care Center in Greece , 2003, European Journal of Clinical Microbiology and Infectious Diseases.
[96] Shane Gillespie,et al. Attributable mortality of nosocomial candidemia, revisited. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[97] J. Meis,et al. Activity of Posaconazole in Treatment of Experimental Disseminated Zygomycosis , 2003, Antimicrobial Agents and Chemotherapy.
[98] R. Luzzati,et al. Nosocomial Cluster of Candida guillermondii Fungemia in Surgical Patients , 2003, European Journal of Clinical Microbiology and Infectious Diseases.
[99] B. Spellberg,et al. Liposomal Amphotericin B, and Not Amphotericin B Deoxycholate, Improves Survival of Diabetic Mice Infected with Rhizopus oryzae , 2003, Antimicrobial Agents and Chemotherapy.
[100] J. Quenot,et al. Candidemia in critically ill patients: difference of outcome between medical and surgical patients , 2003, Intensive Care Medicine.
[101] J. Thornby,et al. Candidemia in a Tertiary Care Cancer Center: In Vitro Susceptibility and its Association with Outcome of Initial Antifungal Therapy , 2003, Medicine.
[102] W. Powderly,et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[103] Reji Thomas,et al. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. , 2003, Indian journal of ophthalmology.
[104] R. Wenzel,et al. Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities , 2003, The Pediatric infectious disease journal.
[105] K. Oshimi,et al. [Zygomycosis: two case reports and review of reported cases in the literature in Japan]. , 2003, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology.
[106] J. Perfect,et al. Global Distribution and Outcomes for Candida Species Causing Invasive Candidiasis: Results from an International Randomized Double-Blind Study of Caspofungin Versus Amphotericin B for the Treatment of Invasive Candidiasis , 2003, European Journal of Clinical Microbiology and Infectious Diseases.
[107] E. Anaissie,et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection , 2003, Cancer.
[108] G. Bernard,et al. Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated). , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[109] S. Dharmage,et al. Influence of Building Construction Work On Aspergillus Infection in a Hospital Setting , 2003, Infection Control & Hospital Epidemiology.
[110] J. Miro,et al. Long-term results after cardiac surgery in patients infected with the human immunodeficiency virus type-1 (HIV-1). , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[111] I. Gosbell,et al. Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery , 2003, Mycoses.
[112] J. Sobel,et al. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[113] R. Wenzel,et al. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[114] M. Pfaller,et al. Activities of Fluconazole and Voriconazole against 1,586 Recent Clinical Isolates of Candida Species Determined by Broth Microdilution, Disk Diffusion, and Etest Methods: Report from The ARTEMIS Global Antifungal Susceptibility Program, 2001 , 2003, Journal of Clinical Microbiology.
[115] T. Kazui,et al. Pulmonary resection with chest wall removal and reconstruction for invasive pulmonary mucormycosis during antileukemia chemotherapy. , 2003, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.
[116] D. Caillot. Intravenous Itraconazole followed by Oral Itraconazole for the Treatment of Amphotericin-B-Refractory Invasive Pulmonary Aspergillosis , 2003, Acta Haematologica.
[117] M. Fariñas,et al. Candidemia in a Tertiary Care Hospital: Epidemiology and Factors Influencing Mortality , 2003, European Journal of Clinical Microbiology and Infectious Diseases.
[118] M. Manfait,et al. Use of Fourier-Transform Infrared Spectroscopy for Typing of Candidaalbicans Strains Isolated in Intensive Care Units , 2003, Journal of Clinical Microbiology.
[119] J. Sobel,et al. Incident and Persistent Vulvovaginal Candidiasis Among Human Immunodeficiency Virus–Infected Women: Risk Factors and Severity , 2003, Obstetrics and gynecology.
[120] A. Schwarer,et al. Successful Control of Disseminated Scedosporium prolificans Infection with a Combination of Voriconazole and Terbinafine , 2003, European Journal of Clinical Microbiology and Infectious Diseases.
[121] J. Perfect,et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. , 2002, The New England journal of medicine.
[122] M. Boeckh,et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. , 2002, Blood.
[123] P. Duvaldestin,et al. Molecular diversity and routes of colonization of Candida albicans in a surgical intensive care unit, as studied using microsatellite markers. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[124] E. Anaissie,et al. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[125] Kerrayem Alsuwaida. Primary cutaneous mucormycosis complicating the use of adhesive tape to secure the endotracheal tube , 2002, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[126] K. Ohtomo,et al. The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis. An autopsy‐based retrospective study of 48 patients , 2002, Mycoses.
[127] A. Böhme,et al. Risikofaktoren für invasive Zygomykosen bei Patienten mit hämatologischen Neoplasien , 2002 .
[128] D. Armstrong,et al. Prospective epidemiologic analysis of triazole-resistant nosocomial Candida glabrata isolated from patients at a comprehensive cancer center. , 2002, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[129] J. Wingard,et al. A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[130] Richard Sylvester,et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. , 2002, The New England journal of medicine.
[131] C. Maslo,et al. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. , 2002, The Journal of hospital infection.
[132] D. Loebenberg,et al. In Vivo Activity of Posaconazole against Mucor spp. in an Immunosuppressed-Mouse Model , 2002, Antimicrobial Agents and Chemotherapy.
[133] B. Kullberg,et al. Epidemiology of opportunistic invasive mycoses. , 2002, European journal of medical research.
[134] J. Graybill,et al. In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of Zygomycetes , 2002, Antimicrobial Agents and Chemotherapy.
[135] L. Ekelund,et al. Early chest radiography and CT in the diagnosis, management and outcome of invasive pulmonary aspergillosis. , 2002, Acta radiologica.
[136] B. D. de Pauw,et al. Impaired gut function as risk factor for invasive candidiasis in neutropenic patients , 2002, British journal of haematology.
[137] Y. Kanda,et al. Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy‐based study involving 720 patients with haematological malignancy , 2002, British journal of haematology.
[138] M. Pfaller,et al. Epidemiology of Candidemia: 3-Year Results from the Emerging Infections and the Epidemiology of Iowa Organisms Study , 2002, Journal of Clinical Microbiology.
[139] M. Pfaller,et al. Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000 , 2002, Antimicrobial Agents and Chemotherapy.
[140] Lawrence Corey,et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[141] E. Anaissie,et al. Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[142] A. Sterrett,et al. Single- and Multiple-Dose Pharmacokinetics of Caspofungin in Healthy Men , 2002, Antimicrobial Agents and Chemotherapy.
[143] S. Joly,et al. Carriage Frequency, Intensity of Carriage, and Strains of Oral Yeast Species Vary in the Progression to Oral Candidiasis in Human Immunodeficiency Virus-Positive Individuals , 2002, Journal of Clinical Microbiology.
[144] H. Giamarellou. Nosocomial cardiac infections. , 2002, The Journal of hospital infection.
[145] H. Kantarjian,et al. Masking of Neutropenic Patients on Transport From Hospital Rooms Is Associated With a Decrease in Nosocomial Aspergillosis During Construction , 2002, Infection Control & Hospital Epidemiology.
[146] V. Rickerts,et al. [Risk factor for invasive zygomycosis in patients with hematologic malignancies]. , 2002, Mycoses.
[147] W. Hope,et al. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. , 2002, The Journal of hospital infection.
[148] D. Denning,et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[149] J. Beney,et al. The direct cost and incidence of systemic fungal infections. , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[150] J. Devlin,et al. Temporal assessment of Candida risk factors in the surgical intensive care unit. , 2001, Archives of surgery.
[151] S. Chanock,et al. Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[152] A. Çağatay,et al. Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report , 2001, BMC infectious diseases.
[153] R. Hajjeh,et al. Counterpoint: invasive aspergillosis and the environment--rethinking our approach to prevention. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[154] S. Singhal,et al. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome , 2001, Bone Marrow Transplantation.
[155] H. Prentice,et al. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[156] P. Vos,et al. Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non–bone marrow transplant setting , 2001, Cancer.
[157] G. Samonis,et al. Effects of Cefepime and Meropenem on the Gastrointestinal Colonization ofSurgical Patients by Candida albicans , 2001, Chemotherapy.
[158] J. Brieland,et al. Comparison of Pathogenesis and Host Immune Responses to Candida glabrata and Candida albicans in Systemically Infected Immunocompetent Mice , 2001, Infection and Immunity.
[159] F. Derouin,et al. Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients. , 2001, The Journal of hospital infection.
[160] D. Perlin,et al. Prospective Study of Candida Species in Patients at a Comprehensive Cancer Center , 2001, Antimicrobial Agents and Chemotherapy.
[161] J. Guarro,et al. In Vitro Activities of Four Novel Triazoles againstScedosporium spp , 2001, Antimicrobial Agents and Chemotherapy.
[162] E. Anaissie,et al. Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[163] E. Daar,et al. The Epidemiology of Invasive Pulmonary Aspergillosis at a Large Teaching Hospital , 2001, Infection Control & Hospital Epidemiology.
[164] R. Dhanireddy,et al. Association of Postnatal Dexamethasone Use and Fungal Sepsis in the Development of Severe Retinopathy of Prematurity and Progression to Laser Therapy in Extremely Low-Birth-Weight Infants , 2001, Journal of Perinatology.
[165] J. Baddley,et al. Invasive mold infections in allogeneic bone marrow transplant recipients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[166] C. Payá,et al. Fusarium infection after solid-organ transplantation. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[167] Y. Tselentis,et al. Prospective Evaluation of the Impact of Amoxicillin, Clarithromycin and Their Combination on Human Gastrointestinal Colonization by Candida Species , 2001, Chemotherapy.
[168] J. Rowe,et al. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: Before and after chemoprophylaxis and institution of HEPA filters , 2001, American journal of hematology.
[169] M. Libman,et al. Prevalence and Antifungal Susceptibility of 442Candida Isolates from Blood and Other Normally Sterile Sites: Results of a 2-Year (1996 to 1998) Multicenter Surveillance Study in Quebec, Canada , 2001, Journal of Clinical Microbiology.
[170] H. Kantarjian,et al. Comparison of Amphotericin B Lipid Complex (ABLC) vs. AmBisome in the Treatment of Suspected or Documented Fungal Infections in Patients with Leukemia , 2001, Leukemia & lymphoma.
[171] R. Khatib,et al. Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital. , 2001, Scandinavian journal of infectious diseases.
[172] Y. Tselentis,et al. The impact of norfloxacin, ciprofloxacin and ofloxacin on human gut colonization by Candida albicans. , 2001, Scandinavian journal of infectious diseases.
[173] S. Fanello,et al. Nosocomial Candida albicans acquisition in a geriatric unit: epidemiology and evidence for person-to-person transmission. , 2001, The Journal of hospital infection.
[174] A. Bernard,et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[175] M. Essmann,et al. Candidiasis During Pregnancy May Result From Isogenic Commensal Strains , 2001, Infectious diseases in obstetrics and gynecology.
[176] E. Anaissie,et al. Predictors of outcome in cancer patients with candidemia. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[177] S. Saint,et al. Four year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient outcome. , 2000, Diagnostic microbiology and infectious disease.
[178] A. Fauser,et al. Review of comparative studies between conventional and liposomal amphotericin B (Ambisome®) in neutropenic patients with fever of unknown origin and patients with systemic mycosis , 2000, Mycoses.
[179] In vitro effects of interleukin-10, prednisolone, and GM-CSF on the non-specific immune function of human polymorphonuclear leucocytes and monocytes. , 2000, European journal of medical research.
[180] Klempp‐Selb,et al. Karyotyping of Candida albicans and Candida glabrata from patients with Candida sepsis , 2000, Mycoses.
[181] S. Piscitelli,et al. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. , 2000, The Journal of infectious diseases.
[182] D. Kontoyiannis,et al. Zygomycosis in the 1990s in a tertiary-care cancer center. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[183] H. Einsele,et al. Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening. , 2000, The Journal of infectious diseases.
[184] D. Denning,et al. Practice Guidelines for Diseases Caused by Aspergillus , 2000 .
[185] L. Saiman,et al. Risk factors for candidemia in Neonatal Intensive Care Unit patients , 2000, The Pediatric infectious disease journal.
[186] J. Ribes,et al. Zygomycetes in human disease. , 2000, Clinical microbiology reviews.
[187] Scott B. Johnson,et al. Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients , 2000, Transplant infectious disease : an official journal of the Transplantation Society.
[188] H. Ho,et al. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) , 1997, Expert opinion on investigational drugs.
[189] G. Rennert,et al. Epidemiology of Candidemia – A Nationwide Survey in Israel , 2000, Infection.
[190] S. Bellino,et al. Nosocomial Candidemia in Non-Neutropenic Patients at an Italian Tertiary Care Hospital , 2000, European Journal of Clinical Microbiology and Infectious Diseases.
[191] T. C. White,et al. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. , 2000, The Journal of infectious diseases.
[192] C. Bolliger,et al. Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis , 1999, Bone Marrow Transplantation.
[193] J. Perfect,et al. Diagnosis and treatment of oropharyngeal candidiasis in patients infected with HIV: a critical reassessment. , 1999, AIDS research and human retroviruses.
[194] R. Pinner,et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[195] J. Šufliarský,et al. Nosocomial candidaemias due to species other than Candida albicans in cancer patients , 1999, Supportive Care in Cancer.
[196] L. Saiman,et al. Elucidating the Origins of Nosocomial Infections with Candida albicans by DNA Fingerprinting with the Complex Probe Ca3 , 1999, Journal of Clinical Microbiology.
[197] L. Mele,et al. Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes , 1999, European journal of haematology.
[198] R. Salomão,et al. High rate of non-albicans candidemia in Brazilian tertiary care hospitals. , 1999, Diagnostic microbiology and infectious disease.
[199] G. Verhoef,et al. Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis , 1999, Bone Marrow Transplantation.
[200] L. Saiman,et al. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[201] D. McClish,et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[202] S. Sanche,et al. In Vitro Amphotericin B Resistance in Clinical Isolates of Aspergillus terreus, with a Head-to-Head Comparison to Voriconazole , 1999, Journal of Clinical Microbiology.
[203] G. Fadda,et al. Candidemia in HIV-Infected Subjects , 1999, European Journal of Clinical Microbiology and Infectious Diseases.
[204] A. Borzotta,et al. Candida infections in critically ill trauma patients: a retrospective case-control study. , 1999, Archives of surgery.
[205] P. Francioli,et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. , 1999, Critical care medicine.
[206] M. Arisawa,et al. Epidemiology of Visceral Mycoses: Analysis of Data in Annual of the Pathological Autopsy Cases in Japan , 1999, Journal of Clinical Microbiology.
[207] A. Michalopoulos,et al. Severe sepsis in cardiac surgical patients. , 2003, The European journal of surgery = Acta chirurgica.
[208] R. Pinner,et al. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[209] W. Jänisch,et al. Vorkommen von Endomykosen im Obduktionsgut der Berliner Charité , 1998 .
[210] D. Niederwieser,et al. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. , 1998, The Journal of antimicrobial chemotherapy.
[211] M. Ghannoum,et al. Mechanism of Fluconazole Resistance inCandida krusei , 1998, Antimicrobial Agents and Chemotherapy.
[212] A. Espinel-Ingroff. Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts , 1998, Journal of Clinical Microbiology.
[213] R Sylvester,et al. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. , 1998, The Journal of infection.
[214] P. Kvale,et al. Risk Factors and Outcomes Associated With Identification of Aspergillus in Respiratory Specimens From Persons With HIV Disease , 1998 .
[215] J. Rich,et al. Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases. , 1998, Chest.
[216] K. Cherian,et al. Fungal endocarditis following cardiac surgery. , 1998, Indian heart journal.
[217] E. Kossoff,et al. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. , 1998, The Pediatric infectious disease journal.
[218] E. Anaissie,et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[219] M. A. Martin,et al. National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. , 1998, Diagnostic microbiology and infectious disease.
[220] J. Bagg,et al. Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients. , 1998, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[221] O. Lortholary,et al. Candidemia: a nosocomial complication in adults with late-stage AIDS. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[222] S. Špánik,et al. Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. , 1998, The Journal of antimicrobial chemotherapy.
[223] E. Anaissie,et al. Predictors of adverse outcome in cancer patients with candidemia. , 1998, The American journal of medicine.
[224] W. Wilson,et al. Successful medical management of isolated renal zygomycosis: case report and review. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[225] C. Chenoweth,et al. Risk factors for candidemia in a children's hospital. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[226] C. K. Campbell,et al. Rhizopus microsporus in wooden tongue depressors: a major threat or minor inconvenience? , 1998, The Journal of hospital infection.
[227] J. Sobel,et al. Nosocomial Candida glabrata Colonization: an Epidemiologic Study , 1998, Journal of Clinical Microbiology.
[228] M. Carrier,et al. Epidemiological study of Candida spp. colonization in cardiovascular surgical patients , 1997, Mycoses.
[229] J. Karlowsky,et al. Candidemia in a Canadian tertiary care hospital from 1976 to 1996. , 1997, Diagnostic microbiology and infectious disease.
[230] M. Antunes,et al. Mediastinitis after aorto-coronary bypass surgery. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[231] M. Del Poeta,et al. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds , 1997, Antimicrobial agents and chemotherapy.
[232] J. Quivey,et al. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. , 1997, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[233] E. Anaissie,et al. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. , 1997, Blood.
[234] E. Abemayor,et al. Rhinocerebral Mucormycosis: Evolution of the Disease and Treatment Options , 1997, The Laryngoscope.
[235] M. Ghannoum,et al. International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[236] W. Leisenring,et al. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. , 1997, The Journal of infectious diseases.
[237] R. Wenzel,et al. Nosocomial Candida. Epidemiology, transmission, and prevention. , 1997, Infectious disease clinics of North America.
[238] B. Crowley,et al. Cutaneous mucormycosis due to Absidia corymbifera occurring after bone marrow transplantation , 1997, Bone Marrow Transplantation.
[239] S. Špánik,et al. Fungemia in cancer patients undergoing chemotherapy versus surgery: risk factors, etiology and outcome. , 1997, Scandinavian journal of infectious diseases.
[240] K. Shirabe,et al. Impaired systemic immunity and frequent infection in patients with Candida antigen after hepatectomy. , 1997, Hepato-gastroenterology.
[241] A. Sitges-Serra,et al. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy , 1997, Intensive Care Medicine.
[242] G. Nimmo,et al. Rhizopusand tongue depressors , 1996, The Lancet.
[243] V. Loo,et al. Control of Construction-Associated Nosocomial Aspergillosis in an Antiquated Hematology Unit , 1996, Infection Control & Hospital Epidemiology.
[244] J. Chave,et al. Asymptomatic oral yeast carriage in HIV-infected patients: frequency and fluconazole susceptibility profile. , 1996, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[245] E. Anaissie,et al. The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[246] Yee-Chun Chen,et al. Nosocomial candidemia in a university hospital in Taiwan. , 1996, Journal of the Formosan Medical Association = Taiwan yi zhi.
[247] G. Nimmo,et al. Subcutaneous Zygomycosis Due To Saksenaea Vasiformis: Rapid isolate identification using a modified sporulation technique , 1996, Pathology.
[248] M. Nucci,et al. Fungal infections in neutropenic patients. A 8-year prospective study. , 1995, Revista do Instituto de Medicina Tropical de Sao Paulo.
[249] S. Werner,et al. Nosocomial outbreak of Candida albicans sternal wound infections following cardiac surgery traced to a scrub nurse. , 1995, The Journal of infectious diseases.
[250] T. Parkinson,et al. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata , 1995, Antimicrobial agents and chemotherapy.
[251] M. Pfaller,et al. Epidemiology of candidiasis. , 1995, The Journal of hospital infection.
[252] R. Wenzel. Nosocomial candidemia: risk factors and attributable mortality. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[253] W. Jarvis. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[254] R. Duthie,et al. Aspergillus fungemia: report of two cases and review. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[255] J. Bueno,et al. [Fungal infections in neutropenic patients]. , 1995, Sangre.
[256] R. Auckenthaler,et al. Candida Colonization and Subsequent Infections in Critically III Surgical Patients , 1994, Annals of surgery.
[257] M. Levenstein,et al. A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia , 1994 .
[258] M. Schmidt,et al. Glucocorticoid-induced alterations of monocyte defense mechanisms against Candida albicans. , 1994, Cellular immunology.
[259] R. Rubin,et al. Clinical aspects of fungal infection in organ transplant recipients. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[260] J. Perfect,et al. NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. , 1994, The American journal of medicine.
[261] R. D. Adam,et al. Mucormycosis: emerging prominence of cutaneous infections. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[262] C. E. Davis,et al. Cutaneous zygomycosis caused by Saksenaea vasiformis in a diabetic patient , 1994, Journal of clinical microbiology.
[263] V. Morrison,et al. Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome. , 1994, The American journal of medicine.
[264] E. Anaissie,et al. Infections due to Cunninghamella bertholletiae in patients with cancer: report of three cases and review. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[265] Y. Schneider,et al. Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus. , 1994, Biochemical pharmacology.
[266] B. Doebbeling,et al. Investigation of the sequence of colonization and candidemia in nonneutropenic patients , 1994, Journal of clinical microbiology.
[267] J. Lowe,et al. Pulmonary mucormycosis: results of medical and surgical therapy. , 1994, The Annals of thoracic surgery.
[268] R. Crichton,et al. Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. , 1994, Kidney international.
[269] O. Zmora,et al. Altered gut barrier function to Candida during parenteral nutrition. , 1994, Nutrition.
[270] R. Ali,et al. Cokeromyces recurvatus, a mucoraceous zygomycete rarely isolated in clinical laboratories , 1994, Journal of clinical microbiology.
[271] W. Hall,et al. Rhinocerebral mucormycosis: changing patterns of disease. , 1994, Surgical neurology.
[272] R. Khatib,et al. Candidemia: current epidemiologic characteristics and a long-term follow-up of the survivors. , 1994, Scandinavian journal of infectious diseases.
[273] F. Bongard,et al. Candida sepsis in surgical patients. , 1993, American journal of surgery.
[274] F. Mandelli,et al. Fungemia in Patients with Leukemia , 1993, The American journal of the medical sciences.
[275] A. Telenti,et al. Candidemia from a urinary tract source: microbiological aspects and clinical significance. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[276] C. C. Patrick,et al. Cunninghamella infections: review and report of two cases of Cunninghamella pneumonia in immunocompromised children. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[277] F. Stock,et al. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. , 1993, Diagnostic microbiology and infectious disease.
[278] H. Bingham,et al. Natural history of bloodstream infections in a burn patient population: the importance of candidemia. , 1993, American journal of infection control.
[279] A. Venot,et al. Prognostic factors of invasive pulmonary aspergillosis in leukemic patients. , 1993, Leukemia & lymphoma.
[280] Morrison Va,et al. Mucormycosis in the BMT population , 1993 .
[281] Y. Schneider,et al. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. , 1993, The Journal of clinical investigation.
[282] A. Tärnvik,et al. A case of chronic progressive rhinocerebral mucormycosis treated with liposomal amphotericin B and surgery. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[283] J. Armitage,et al. Nosocomial Invasive Aspergillosis in Lymphoma Patients Treated with Bone Marrow or Peripheral Stem Cell Transplants , 1993, Infection Control & Hospital Epidemiology.
[284] V. Fraser,et al. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[285] F. Meunier,et al. Candidemia in immunocompromised patients. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[286] W. Martone,et al. Predominant pathogens in hospital infections. , 1992, The Journal of antimicrobial chemotherapy.
[287] I. Chopra,et al. Uptake of minocycline by Escherichia coli. , 1992, The Journal of antimicrobial chemotherapy.
[288] H. Richet,et al. Risk factors for candidemia in patients with acute lymphocytic leukemia. , 1991, Reviews of infectious diseases.
[289] P. Fenaux,et al. Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. , 1991, The Journal of antimicrobial chemotherapy.
[290] R. Wenzel,et al. Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[291] B. Dupont. Itraconazole therapy in aspergillosis: study in 49 patients. , 1990, Journal of the American Academy of Dermatology.
[292] R. Douglas,et al. Agents of mucormycosis and related species. , 1990 .
[293] P. Francioli,et al. CLINICAL SIGNIFICANCE OF CANDIDA ISOLATED FROM PERITONEUM IN SURGICAL PATIENTS , 1989, The Lancet.
[294] B. Strom,et al. Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. , 1989, The American journal of medicine.
[295] F. Mandelli,et al. Candida colonization and systemic infection in neutropenic patients. A retrospective study , 1989, Cancer.
[296] R. Woolson,et al. Risk factors for hospital-acquired candidemia. A matched case-control study. , 1989, Archives of internal medicine.
[297] T. Rogers,et al. Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. , 1989, The Journal of hospital infection.
[298] K. Cummings,et al. Incidence of nosocomial aspergillosis in patients with leukemia over a twenty-year period. , 1989 .
[299] N. Khardori,et al. Cutaneous Rhizopus and Aspergillus infections in five patients with cancer. , 1989, Archives of dermatology.
[300] R. Rubin,et al. Invasive aspergillus infection: possible non-ward common source within the hospital environment. , 1989, The Journal of hospital infection.
[301] R F Woolson,et al. Hospital-acquired candidemia. The attributable mortality and excess length of stay. , 1988, Archives of internal medicine.
[302] C. Hill,et al. Risk factors for candidemia in cancer patients: a case-control study , 1988, Journal of clinical microbiology.
[303] B. Kramer,et al. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. , 1987, The American journal of medicine.
[304] M. Piens,et al. Invasive nosocomial pulmonary aspergillosis: risk factors and hospital building works , 1987, Epidemiology and Infection.
[305] Douglas Lj. Adhesion of Candida species to epithelial surfaces. , 1987 .
[306] E. Anaissie,et al. Pneumonia with cunninghamella species in patients with hematologic malignancies: A case report and review of the literature , 1986, Cancer.
[307] V. Yu,et al. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. , 1986, The American journal of medicine.
[308] D. Rotrosen,et al. Adherence of Candida species to host tissues and plastic surfaces. , 1986, Reviews of infectious diseases.
[309] K. Digre,et al. Adherence of Candida species to human epidermal corneocytes and buccal mucosal cells: correlation with cutaneous pathogenicity. , 1984, The Journal of investigative dermatology.
[310] E. Segal,et al. In vitro and in vivo adherence of Candida albicans to mucosal surfaces. , 1983, Annales de microbiologie.
[311] A. Callow,et al. Candida Infections in Surgical Patients , 1983, Annals of surgery.
[312] W. Lee,et al. Candida infections in patients with acute leukemia: Ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis , 1982, Cancer.
[313] M. Okada,et al. Present state of fungal infections in autopsy cases in Japan. , 1980, American journal of clinical pathology.
[314] D. Armstrong,et al. The prevalence of yeasts in clinical specimens from cancer patients. , 1980, American journal of clinical pathology.
[315] A. Kamalam,et al. Cutaneous infection by Syncephalastrum. , 1980, Sabouraudia.
[316] J. Mead,et al. Cutaneous Rhizopus infection. Occurrence as a postoperative complication associated with an elasticized adhesive dressing. , 1979, JAMA.
[317] John E. Bennett,et al. Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .
[318] G. Keusch,et al. Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment. , 1978, The New England journal of medicine.
[319] W. R. Waters,et al. Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis. , 1978, Canadian Medical Association journal.
[320] Arnow Pm,et al. Pumonary aspergillosis during hospital renovation. , 1978 .
[321] A. Bayer,et al. Candida peritonitis. Report of 22 cases and review of the English literature. , 1976, The American journal of medicine.
[322] A. Seaton,et al. Sources and incidence of airborne Aspergillus fumigatus (Fres) , 1976, Clinical allergy.
[323] K. Kwon-Chung,et al. Pulmonary mucormycosis caused by Cunninghamella elegans in a patient with chronic myelogenous leukemia. , 1975, American journal of clinical pathology.
[324] H. Stone,et al. Candida sepsis: pathogenesis and principles of treatments. , 1974, Annals of surgery.
[325] I. Feller,et al. Monilial sepsis in the surgical patient. , 1972, The Surgical clinics of North America.
[326] Remington Js,et al. Disseminated candidiasis in the surgical patient. , 1972 .
[327] W. Krause,et al. Fungaemia and funguria after oral administration of Candida albicans. , 1969, Lancet.
[328] R. Hurley,et al. The growth of Candida species in cultures of mouse peritoneal macrophages , 1969, The Journal of pathology.
[329] M. Seelig. The role of antibiotics in the pathogenesis of Candidainfections. , 1966, The American journal of medicine.
[330] J. Enders,et al. Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.